参考文献/References:
[1] Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin, 2020, 70(3):145-164.
[2] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin, 2020, 70(1): 7-30.
[3] Guo Z, Zhang J, Wang Z, et al. Intestinal Microbiota Distinguish Gout Patients from Healthy Humans. Sci Rep, 2016, 6: 20602.
[4] Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature, 2014, 513(7516): 59-64.
[5] Yang J, Li D, Yang Z, et al. Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families. Gut Microbes, 2020, 11(4): 918-929.
[6] Murphy N, Moreno V, Hughes D J, et al. Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Mol Aspects Med, 2019, 69: 2-9.
[7] O'keefe SJ. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol, 2016, 13(12): 691-706.
[8] Zhang J, Guo Z, Xue Z, et al. A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities. ISME J, 2015, 9(9): 1979-1990.
[9] Dai Z, Coker OO, Nakatsu G, et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome, 2018, 6(1): 70.
[10] Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor immune microenvironment. Cell Host Microbe, 2013, 14(2):207-215.
[11] Nosho K, Sukawa Y, Adachi Y, et al. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. World J Gastroenterol, 2016, 22(2): 557-566.
[12] Boleij A, Hechenbleikner EM, Goodwin AC, et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis, 2015, 60(2): 208-215.
[13] Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, et al. Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli. Nature, 2020, 580(7802):269-273.
[14] Song M, Chan AT, Sun J. Influence of the Gut Microbiome, Diet,and Environment on Risk of Colorectal Cancer. Gastroenterology,2020, 158(2): 322-340.
[15] Xie YH, Gao QY, Cai GX, et al. Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies. EBioMedicine, 2017, 25:32-40.
[16] 彭倩楠, 霍冬雪, 徐传标,等. 黎族人肠道微生物群落结构特征及其与饮食关联性. 微生物学通报. 2017, 44(11): 2624-2633.
[17] 中华人民共和国卫生和计划生育委员会医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2017年版). 中国实用外科杂志, 2018, 38(10): 1089-1103.
[18] Langmead B, Trapnell C, Pop M, et al. Ultrafast and memory efficient alignment of short DNA sequences to the human genome. Genome Biol, 2009, 10(3): R25.
[19] Rosenbloom KR, Armstrong J, Barber GP, et al. The UCSC Genome Browser database: 2015 update. Nucleic Acids Res, 2015, 43(Database issue): D670-D681.
[20] Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol, 2014, 15(3):R46.
[21] Lu J, Breitwieser FP, Thielen P, et al. Bracken: estimating species abundance in metagenomics data. PeerJ Computer Science, 2017,3(1): e104.
[22] Franzosa EA, Mciver LJ, Rahnavard G, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods, 2018, 15(11): 962-968.
[23] Mallick H, Franzosa EA, Mclver LJ, et al. Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences. Nat Commun, 2019, 10(1): 3136.
[24] Jia B, Raphenya AR, Alcock B, et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res, 2017, 45(D1): D566-D573.
[25] Martino C, Morton JT, Marotz CA, et al. A Novel Sparse Compositional Technique Reveals Microbial Perturbations. mSystems, 2019, 4(1): e00016-e00019.
[26] Vogtmann E, Hua X, Zeller G, et al. Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing. PLoS One, 2016, 11(5): e0155362.
[27] Yu J, Feng Q, Wong SH, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut, 2017, 66(1): 70-78.
[28] Chen D, Jin D, Huang S, et al. Clostridium butyricum, a butyrate producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett, 2020, 469:456-467.
[29] Huang CC, Shen MH, Chen SK, et al. Gut butyrate-producing organisms correlate to Placenta Specific 8 protein: Importance to colorectal cancer progression. J Adv Res, 2020, 22:7-20.
[30] Mizutani S, Yamada T, Yachida S. Significance of the gut microbiome in multistep colorectal carcinogenesis. Cancer Sci,2020, 111(3):766-773.
[31] Ai D, Pan H, Han R, et al. Using Decision Tree Aggregation with Random Forest Model to Identify Gut Microbes Associated with Colorectal Cancer. Genes (Basel), 2019, 10(2):112.
[32] Gupta A, Dhakan DB, Maji A, et al. Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India. mSystems,2019, 4(6): e00438-19
[33] Abed J, Emgard JE, Zamir G, et al. Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc. Cell Host Microbe, 2016, 20(2):215-225.
[34] Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe,2013, 14(2): 195-206.
[35] Mima K, Sukawa Y, Nishihara R, et al. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol, 2015, 1(5):653-661.